Background: Glucocorticoids (GCs) are considered drugs of choice for treating nasal polyps (NPs). However, a subset of patients shows a limited clinical response even to high doses of GCs. Altered expression of glucocorticoid receptors (GRs), namely GR-α and GR-β, is a potential mechanism underlying GC insensitivity. GCs modulate the expression of several cytokines, including transforming growth factor-β (TGF-β), which may contribute to cellular proliferation in NPs. The study investigates some biomolecular features of GC-resistant NPs, and examines possible differences from normal mucosa (NM). Methodology: Radioligand binding assay (binding) was used to determine GR-α binding capacity; Western blotting was used to evaluate GR-α, GR-β, and TGF-β expression and GR-α subcellular distribution. NPs were sampled in 32 patients during ethmoidectomy; NM was taken from 15 healthy patients during rhinoplasty. Results: GR-α was present in NPs and NM, with lower affinity for the ligand in NPs. GR-α was prevalent in the cytosol of NPs that were GR-α-negative to the binding assay. GR-β was expressed in NPs and absent in the majority of NM. TGF-β1 expression was higher in NPs than in NM.

Steroid resistance in nasal polyposis: role of glucocorticoid receptor and TGF-beta1.

AVERSA, SALVATORE;ABBADESSA, Giuliana;PICCIONE, Francesca;CARRIERO, VITINA MARIA ANNA;DE FRANCIA, SILVIA;RACCA, Silvia Anna
2012-01-01

Abstract

Background: Glucocorticoids (GCs) are considered drugs of choice for treating nasal polyps (NPs). However, a subset of patients shows a limited clinical response even to high doses of GCs. Altered expression of glucocorticoid receptors (GRs), namely GR-α and GR-β, is a potential mechanism underlying GC insensitivity. GCs modulate the expression of several cytokines, including transforming growth factor-β (TGF-β), which may contribute to cellular proliferation in NPs. The study investigates some biomolecular features of GC-resistant NPs, and examines possible differences from normal mucosa (NM). Methodology: Radioligand binding assay (binding) was used to determine GR-α binding capacity; Western blotting was used to evaluate GR-α, GR-β, and TGF-β expression and GR-α subcellular distribution. NPs were sampled in 32 patients during ethmoidectomy; NM was taken from 15 healthy patients during rhinoplasty. Results: GR-α was present in NPs and NM, with lower affinity for the ligand in NPs. GR-α was prevalent in the cytosol of NPs that were GR-α-negative to the binding assay. GR-β was expressed in NPs and absent in the majority of NM. TGF-β1 expression was higher in NPs than in NM.
50
4
427
435
Aversa S; Ondolo C; Abbadessa G; Piccione F; Carriero V; Fulcheri A; Lauria A; De Francia S; Racca S.
File in questo prodotto:
File Dimensione Formato  
Racca S Rhinology.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 190.99 kB
Formato Adobe PDF
190.99 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/130781
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact